Published in Infect Immun on October 01, 1982
Heterosubtypic immunity to influenza A virus: where do we stand? Microbes Infect (2008) 1.88
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun (1984) 1.52
Enhancement of anti-influenza A virus cytotoxicity following influenza A virus vaccination in older, chronically ill adults. J Clin Microbiol (1990) 1.31
Safety, immunogencity, and efficacy of a cold-adapted A/Ann Arbor/6/60 (H2N2) vaccine in mice and ferrets. Virology (2009) 1.09
Alpha-C-galactosylceramide as an adjuvant for a live attenuated influenza virus vaccine. Vaccine (2009) 1.05
New aspects of influenza viruses. Clin Microbiol Rev (1992) 0.97
Virus growth and antibody responses following respiratory tract infection of ferrets and mice with WT and P/V mutants of the paramyxovirus Simian Virus 5. Virology (2008) 0.90
The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses. Immunology (1984) 0.90
Defective interfering influenza virus inhibits immunopathological effects of infectious virus in the mouse. J Virol (1992) 0.82
Diverse heterologous primary infections radically alter immunodominance hierarchies and clinical outcomes following H7N9 influenza challenge in mice. PLoS Pathog (2015) 0.76
Sensitization of mice with wild-type and cold-adapted influenza virus variants: immune response to two H1N1 and H3N2 viruses. J Virol (1985) 0.75
A procedure for removing red cells and dead cells from lymphoid cell suspensions. J Immunol Methods (1975) 4.22
Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet (1979) 3.55
Adaptation and growth characteristics of influenza virus at 25 degrees c. Nature (1967) 3.41
Cytotoxic T cells specific for influenza virus-infected target cells. Immunology (1977) 2.24
An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses. Immunol Rev (1981) 1.91
Cold adapted variants of influenza A. II. Comparison of the genetic and biological properties of ts mutants and recombinants of the cold adapted A/AA/6/60 strain. Arch Virol (1977) 1.81
A murine model for assessment of living attenuated influenza A vaccines. Aust J Exp Biol Med Sci (1980) 1.62
Production of DTH in the mouse to influenza virus: comparison with conditions for stimulation of cytotoxic T cells. Scand J Immunol (1980) 1.36
Different functions of subsets of effector T cells in murine influenza virus infection. Cell Immunol (1982) 1.33
Vaccination against influenza: a five-year study in the Post Office. J Hyg (Lond) (1979) 1.06
Induction of natural killer cells during murine influenza virus infection. Immunobiology (1981) 1.00
Studies on the pathogenesis of influenzal pneumonitis; intranasal vs. intravenous infection of mice. Yale J Biol Med (1956) 0.98
Influenza virus infection of a newborn rats: virulence of recombinant strains prepared from a cold-adapted, attenuated parent. Arch Virol (1979) 0.96
The generation of 'cytotoxic' macrophages in mice during infection with influenza A or Sendai virus. Scand J Immunol (1982) 0.93
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
An in vitro reaction between labelled flagellin or haemocyanin and lymphocyte-like cells from normal animals. Immunology (1969) 6.28
Specific inactivation of antigen-reactive cells with 125I-labelled antigen. Nature (1969) 4.58
Antigens in immunity. 8. Localization of 125-I-labelled antigens in the secondary response. Immunology (1965) 4.00
Antigen binding cells in tolerance and immunity. Transplant Rev (1970) 3.08
The immune response to influenza infection. Curr Top Microbiol Immunol (1986) 2.83
Blocking of the lymphocyte antigen receptor site with anti-immunoglobulin sera in vitro. Nature (1970) 2.74
Antigens in immunity. VII. Analysis of immunological memory. Immunology (1965) 2.65
Correlation of grain counts with radioactivity (125I and tritium) in autoradiography. Exp Cell Res (1966) 2.62
Cytotoxic T cells specific for influenza virus-infected target cells. Immunology (1977) 2.24
Cytotoxic T cells in the lungs of mice infected with an influenza A virus. Scand J Immunol (1978) 2.13
A morphological examination of antigen reactive cells from mouse spleen and peritoneal cavity. Exp Cell Res (1969) 1.92
An analysis of effector T cell generation and function in mice exposed to influenza A or Sendai viruses. Immunol Rev (1981) 1.91
Low zone tolerance to bacterial flagellin in adult rats: a possible role for antigen localized in lymphoid follicles. Proc Natl Acad Sci U S A (1968) 1.81
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. Neoplasia (1999) 1.78
The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes. Scand J Immunol (1978) 1.62
Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J Neurosci (2001) 1.62
A murine model for assessment of living attenuated influenza A vaccines. Aust J Exp Biol Med Sci (1980) 1.62
Acute myocarditis. Rapid diagnosis by PCR in children. Circulation (1994) 1.58
Role of T-cell function in recovery from murine influenza infection. Cell Immunol (1979) 1.57
Antigen in tissues. IV. The effect of antibody on the retention and localization of antigen in rat lymph nodes. Immunology (1967) 1.56
Cleavage of bacterial flagellin with cyanogen bromide. Antigenic properties of the protein fragments. Biochem J (1969) 1.53
A dual recognition model for cytotoxic T cells based on thymic selection of precursors with low affinity for Self H-2 antigens. Scand J Immunol (1978) 1.53
Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens. Infect Immun (1984) 1.52
Biophysical and biochemical characterization of hepatitis A virus. Intervirology (1982) 1.49
Antigens in immunity. X. Induction of immunologic tolerance to Salmonella adelaide flagellin. J Immunol (1965) 1.49
Disruption of inhibitory G-proteins mediates a reduction in atrial beta-adrenergic signaling by enhancing eNOS expression. Cardiovasc Res (2005) 1.48
The angiosuppressive effects of 20(R)- ginsenoside Rg3. Biochem Pharmacol (2006) 1.47
Renal-coloboma syndrome: report of a novel PAX2 gene mutation. Am J Ophthalmol (2001) 1.46
Distribution of 125I-immunoglobulins, IgG subunits and antigen-antibody complexes in rat lymph nodes. Aust J Exp Biol Med Sci (1969) 1.45
The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants. Scand J Immunol (1987) 1.41
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41
The recovery of mice from influenza A virus infection: adoptive transfer of immunity with influenza virus-specific cytotoxic T lymphocytes recognizing a common virion antigen. Scand J Immunol (1978) 1.36
Production of DTH in the mouse to influenza virus: comparison with conditions for stimulation of cytotoxic T cells. Scand J Immunol (1980) 1.36
Properties of the colony stimulating factor in leukaemic and normal mouse serum. Aust J Exp Biol Med Sci (1968) 1.34
Cleavage of bacterial flagellin with cyanogen bromide. Chemical and physical properties of the protein fragments. Biochem J (1969) 1.34
Different functions of subsets of effector T cells in murine influenza virus infection. Cell Immunol (1982) 1.33
Persistence of influenza virus-specific antibody-secreting cells and B-cell memory after primary murine influenza virus infection. Cell Immunol (1987) 1.32
Influenza virus-specific antibody-secreting cells in the murine lung during primary influenza virus infection. J Virol (1986) 1.32
Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet (1997) 1.29
Bacterial species identification after DNA amplification with a universal primer pair. Mol Genet Metab (1999) 1.25
Live attenuated vaccines against influenza; an historical review. Vaccine (2001) 1.23
Tolerance in adult rats to a purified protein, flagellin, from Salmonella adelaide. Nature (1967) 1.22
A re-examination of the molecular weight of poliovirus RNA. Biochem Biophys Res Commun (1970) 1.18
Quantitation of antibody to non-hemagglutinating viruses by single radial hemolysis: serological test for human coronaviruses. J Clin Microbiol (1977) 1.17
Delayed-type hypersensitivity in the mouse. 3. Inactivation of thymus-derived effector cells and their precursors. Scand J Immunol (1972) 1.17
Ginsenoside Rb1 inhibits tube-like structure formation of endothelial cells by regulating pigment epithelium-derived factor through the oestrogen beta receptor. Br J Pharmacol (2007) 1.16
Evidence that the genome of hepatitis A virus consists of single-stranded RNA. J Virol (1981) 1.14
Minerals, phenolic compounds, and antioxidant capacity of citrus peel extract by hot water. J Food Sci (2008) 1.12
A mathematical model of the murine ventricular myocyte: a data-driven biophysically based approach applied to mice overexpressing the canine NCX isoform. Am J Physiol Heart Circ Physiol (2010) 1.12
Glycerol kinase deficiency: evidence for complexity in a single gene disorder. Hum Genet (2001) 1.10
Recombinant vaccinia viruses as vaccines. Nature (1986) 1.10
Antigen in tissues. V. Effect of endotoxin on the fate of, and on the immun response to, serum albumin and to albumin-antibody complexes. Immunology (1968) 1.08
The anti-angiogenic effect of sinomenine. Angiogenesis (2005) 1.08
A simplified method for quantifying cell migration/wound healing in 96-well plates. J Biomol Screen (2010) 1.08
Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants. Microb Pathog (1986) 1.07
Cells mediating delayed-type hypersensitivity in the lungs of mice infected with an influenza A virus. Scand J Immunol (1980) 1.07
Bis[2,2'-ethylenedioxydibenzaldehyde bis(thiocarbohydrazide)] tris(pyridine) solvate. Acta Crystallogr C (2001) 1.06
Influenza-specific antibody-secreting cells and B cell memory in the murine lung after immunization with wild-type, cold-adapted variant and inactivated influenza viruses. Vaccine (1987) 1.06
The tolerance inducing properties in rats of bacterial flagellin cleaved at the methionine residues. Immunology (1969) 1.06
Observation of a charged charmoniumlike structure in e+ e- → π+ π- J/ψ at sqrt[s] = 4.26 GeV. Phys Rev Lett (2013) 1.05
Amplification of bacterial DNA using highly conserved sequences: automated analysis and potential for molecular triage of sepsis. Pediatrics (1995) 1.04
Effect of helper T cells on the primary in vitro production of delayed-type hypersensitivity to influenza virus. J Exp Med (1981) 1.03
Energy and redox States in the c6 glioma cells following acute exposure to zn, se(+4), and se(+6) and the correlation with apoptosis. Toxicol Mech Methods (2006) 1.01
Genotypic confirmation from the original dried blood specimens in a neonatal hemoglobinopathy screening program. Pediatr Res (1992) 1.01
Observation of electron-antineutrino disappearance at Daya Bay. Phys Rev Lett (2012) 1.00
Neuronal networks controlling thermoregulatory effectors. Prog Brain Res (1998) 1.00
Further characterization of the genetic map of poliovirus temperature-sensitive mutants. In: strategy of the viral genome. Ciba Found Symp (1971) 1.00
Induction of natural killer cells during murine influenza virus infection. Immunobiology (1981) 1.00
Genomic sequence of the DAX1 gene: an orphan nuclear receptor responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. J Clin Endocrinol Metab (1996) 1.00
Improved detection of CFTR mutations in Southern California Hispanic CF patients. Hum Mutat (2001) 1.00
Gamma-irradiated influenza A virus can prime for a cross-reactive and cross-protective immune response against influenza A viruses. Immunol Cell Biol (1988) 0.99
Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity. Neuropharmacology (2006) 0.98
Purified cholera toxin B subunit from transgenic tobacco plants possesses authentic antigenicity. Biotechnol Bioeng (2001) 0.98
The localization of heat denatured serum albumin in rat lymph nodes. Aust J Exp Biol Med Sci (1967) 0.97
Hypothalamic network for thermoregulatory shivering. Am J Physiol (1994) 0.96
Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms). Scand J Immunol (1988) 0.96
Inhibition of HERG K+ current and prolongation of the guinea-pig ventricular action potential by 4-aminopyridine. J Physiol (2003) 0.95
Two T-cell populations mediate delayed-type hypersensitivity to murine influenza virus infection. Scand J Immunol (1980) 0.95
Evidence of synergy between Thy-1 and CD3/TCR complex in signal delivery to murine thymocytes for cell death. J Immunol (1991) 0.95
Cancer survival in Qidong, China, 1992-2000. IARC Sci Publ (2011) 0.94
Genomic scanning for expressed sequences in Xp21 identifies the glycerol kinase gene. Nat Genet (1993) 0.94
Changes in the surface of virus-infected cells recognized by cytotoxic T cells. II. A requirement for glycoprotein synthesis in virus-infected target cells. Scand J Immunol (1976) 0.94
Cytotoxic T cells recognize very early, minor changes in ectromelia virus-infected target cells. Aust J Exp Biol Med Sci (1976) 0.93
Vasodilating and hypotensive effects of fangchinoline and tetrandrine on the rat aorta and the stroke-prone spontaneously hypertensive rat. J Ethnopharmacol (1997) 0.93
Capillary-based fully integrated and automated system for nanoliter polymerase chain reaction analysis directly from cheek cells. J Chromatogr A (2001) 0.93
The generation of 'cytotoxic' macrophages in mice during infection with influenza A or Sendai virus. Scand J Immunol (1982) 0.93
Studies on the anti-tumor activities of the soy isoflavone daidzein on murine neuroblastoma cells. Biomed Pharmacother (2007) 0.92
Antiplatelet activity of green tea catechins is mediated by inhibition of cytoplasmic calcium increase. J Cardiovasc Pharmacol (2001) 0.92
The RNA of human coronavirus OC-43. Virology (1977) 0.92
DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line. Biochem Mol Med (1997) 0.92
Molecular analysis of an additional case of hybrid sterility in rice (Oryza sativa L.). Planta (2010) 0.92
Fibrin gel-immobilized primary osteoblasts in calcium phosphate bone cement: in vivo evaluation with regard to application as injectable biological bone substitute. Cells Tissues Organs (2005) 0.91
Differences in localization of Salmonella flagella in lymph node follicles of germ-free and conventional rats. Nature (1968) 0.91
Characterization of the immunoregulatory action of saikosaponin-d. Cell Immunol (1994) 0.91
Selective suppression of the cytotoxic T cell response to influenza virus in mice. Eur J Immunol (1980) 0.91
PP2A inactivation is a crucial step in triggering apoptin-induced tumor-selective cell killing. Cell Death Dis (2012) 0.90
The sensitization of mice with a wild-type and cold-adapted variant of influenza A virus. II. Secondary cytotoxic T cell responses. Immunology (1984) 0.90